SA PRO
Free Account
Labcorp Holdings Inc.LHNYSE
LOADING
|||
OverviewNewsFundamentalsEarningsAnalysts

Latest News

Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk
prnewswire.com

Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk

Molecular residual disease (MRD) testing detects cancer recurrence months before traditional imaging Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer and stage III colon cancer BURLINGTON, N.C., Jan. 13, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the continued expansion of its molecular residual disease (MRD)i portfolio designed to help clinicians detect cancer recurrence earlier than traditional imaging.

Labcorp Holdings Inc. $LH Shares Sold by Cerity Partners LLC
defenseworld.net

Labcorp Holdings Inc. $LH Shares Sold by Cerity Partners LLC

Cerity Partners LLC decreased its position in shares of Labcorp Holdings Inc. (NYSE: LH) by 5.0% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,384 shares of the medical research company's stock after selling 4,085 shares during the quarter. Cerity

Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs
businesswire.com

Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs

SAN JOSE, Calif.--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will expand national access to the Visby Women's Sexual Health Test, the first, at-home, FDA-authorized PCR test for sexually transmitted infections (STIs) available to consumers, enabling immediate access to Visby's integrated "Test-to-Treat" ecosystem. The palm-sized device delivers confidential results in just 30 minutes, providing women with a rapid response for chlamydia, gonorrhea, and trichomonia.

NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
prnewswire.com

NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp

TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of the Early Development medical device testing business of Labcorp (NYSE: LH), a leading provider of innovative and comprehensive laboratory services. This strategic move underscores NAMSA's commitment to advancing innovation and accelerating time-to-market for MedTech manufacturers worldwide.

Osaic Holdings Inc. Raises Stock Holdings in Labcorp Holdings Inc. $LH
defenseworld.net

Osaic Holdings Inc. Raises Stock Holdings in Labcorp Holdings Inc. $LH

Osaic Holdings Inc. increased its stake in shares of Labcorp Holdings Inc. (NYSE: LH) by 13.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,620 shares of the medical research company's stock after purchasing an additional 4,690

Assenagon Asset Management S.A. Trims Position in Labcorp Holdings Inc. $LH
defenseworld.net

Assenagon Asset Management S.A. Trims Position in Labcorp Holdings Inc. $LH

Assenagon Asset Management S.A. decreased its holdings in shares of Labcorp Holdings Inc. (NYSE: LH) by 69.8% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 36,212 shares of the medical research company's stock after selling 83,746 shares during the quarter. Assenagon Asset

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks
businesswire.com

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures. The financing is intended to accelerate Cofactor's nationwide expansion and broaden patient access to its immunotherapy-response diagnostics. Ascension Ventures, the strategic investment arm of 13 leading U.S. health systems across 22 states, representing more than $100.

Ariel Investments LLC Sells 2,865 Shares of Labcorp Holdings Inc. $LH
defenseworld.net

Ariel Investments LLC Sells 2,865 Shares of Labcorp Holdings Inc. $LH

Ariel Investments LLC lessened its position in Labcorp Holdings Inc. (NYSE: LH) by 0.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 365,398 shares of the medical research company's stock after selling 2,865 shares during the quarter. Ariel Investments

Rep. April McClain Delaney Buys Brown & Brown, Inc. (NYSE:BRO) Stock
defenseworld.net

Rep. April McClain Delaney Buys Brown & Brown, Inc. (NYSE:BRO) Stock

Representative April McClain Delaney (D-Maryland) recently bought shares of Brown and Brown, Inc. (NYSE: BRO). In a filing disclosed on December 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Brown and Brown stock on November 20th. Representative April McClain Delaney also recently made the following trade(s): Sold $1,001 - $15,000 in

Rep. April McClain Delaney Purchases Shares of Labcorp Holdings Inc. (NYSE:LH)
defenseworld.net

Rep. April McClain Delaney Purchases Shares of Labcorp Holdings Inc. (NYSE:LH)

Representative April McClain Delaney (D-Maryland) recently bought shares of Labcorp Holdings Inc. (NYSE: LH). In a filing disclosed on December 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Labcorp stock on November 17th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of Brown

Markel Group (NYSE:MKL) Shares Acquired Rep. April McClain Delaney
defenseworld.net

Markel Group (NYSE:MKL) Shares Acquired Rep. April McClain Delaney

Representative April McClain Delaney (D-Maryland) recently bought shares of Markel Group Inc. (NYSE: MKL). In a filing disclosed on December 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Markel Group stock on November 3rd. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of

EMCOR Group (NYSE:EME) Stock Unloaded Rep. April McClain Delaney
defenseworld.net

EMCOR Group (NYSE:EME) Stock Unloaded Rep. April McClain Delaney

Representative April McClain Delaney (D-Maryland) recently sold shares of EMCOR Group, Inc. (NYSE: EME). In a filing disclosed on December 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in EMCOR Group stock on November 17th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance